| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |